News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

W. R. Grace & Company and FORMAC Pharmaceuticals NV Announce Successful Clinical Trial Demonstrating the Novel Use of Silica for Drug Delivery


4/23/2012 11:06:08 AM

COLUMBIA, Md.--(BUSINESS WIRE)--W. R. Grace & Co. (NYSE: GRA), in partnership with Formac Pharmaceuticals NV, a research and development pharmaceutical company, announced today positive data from initial human studies enabled by the companies’ unique mesoporous silica-based drug delivery technology. This novel technology opens up a viable new avenue for the development of poorly soluble compounds.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES